Archive · 28 Nov 2025
Ozempic 2.0: New Obesity Drug Advances
A new type of pill called Ozempic 2.0 is being developed to help people with obesity and diabetes.
Unlike the current drugs that need to be injected once a week, this new pill can be taken once a day without any special food or water rules.
This makes it easier and more affordable for people to use.
In tests, the pill helped people lose about 9.2% of their body weight, which is more than another similar pill.
However, it might not be as effective as the strongest injectable drugs.
The new pill is still being reviewed by health authorities and could be available in 2026.
This could make it easier for more people to get treatment for obesity and diabetes.
Eli Lilly's orforglipron is a once-daily pill for obesity and diabetes treatment.
The pill does not require food or water restrictions and is easier to distribute.
In trials, it helped patients lose an average of 9.2% of their body weight.
The pill is still under FDA review and could be available in 2026.
Monthly injectable formulations are also being tested to improve patient adherence.
- Who
- Eli Lilly and Novo Nordisk
- What
- Development of new obesity and diabetes drugs
- When
- Expected availability in 2026
- Where
- Global market
- Why
- To improve treatment accessibility and effectiveness
- Drug Name
- Orforglipron
- Company
- Eli Lilly
- Delivery Method
- Once-daily pill
- Weight Loss
- 9.2% average in trials
- FDA Status
- Under review
- Expected Availability
- 2026